Skip to the page

Data / Form D filings / ZBiotics Co

ZBiotics Co: Form D filings

ZBiotics Co, a company in San Francisco, CA, filed 2 Form D notices with the SEC between 2020 and 2024. The latest, on April 9, 2024, reports $22.4 million sold of a $22.4 million offering to 68 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
44 Montgomery Street - Suite 300, San Francisco, CA, 94104
Phone
(415) 723-5294
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1807168

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 9, 2024New notice$22,423,339$22,423,33968Mar 26, 2024sec.gov
Mar 24, 2020New notice$5,691,140$5,691,137$338Mar 5, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Zachary Donald AbbottExecutive Officer, Director
Adam Donald RamadaDirector
Stephen Donald LambExecutive Officer, Director

Other companies in California that filed recently

Every Form D from the week of Apr 8, 2024 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what ZBiotics Co reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.